Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries
IMPORTANCE: Gastroesophageal reflux disease (GERD) is associated with a strong and severity-dependent increased risk of esophageal adenocarcinoma. Whether antireflux surgery prevents esophageal adenocarcinoma is a matter of uncertainty. OBJECTIVES: To examine whether antireflux surgery is associated...
Published in: | JAMA Oncology |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Text |
Language: | English |
Published: |
American Medical Association
2018
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248086/ http://www.ncbi.nlm.nih.gov/pubmed/30422249 https://doi.org/10.1001/jamaoncol.2018.3054 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:6248086 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:6248086 2023-05-15T16:51:55+02:00 Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries Maret-Ouda, John Wahlin, Karl Artama, Miia Brusselaers, Nele Färkkilä, Martti Lynge, Elsebeth Mattsson, Fredrik Pukkala, Eero Romundstad, Pål Tryggvadóttir, Laufey von Euler-Chelpin, My Lagergren, Jesper 2018-08-23 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248086/ http://www.ncbi.nlm.nih.gov/pubmed/30422249 https://doi.org/10.1001/jamaoncol.2018.3054 en eng American Medical Association http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248086/ http://www.ncbi.nlm.nih.gov/pubmed/30422249 http://dx.doi.org/10.1001/jamaoncol.2018.3054 Copyright 2018 American Medical Association. All Rights Reserved. Original Investigation Text 2018 ftpubmed https://doi.org/10.1001/jamaoncol.2018.3054 2019-08-25T00:09:15Z IMPORTANCE: Gastroesophageal reflux disease (GERD) is associated with a strong and severity-dependent increased risk of esophageal adenocarcinoma. Whether antireflux surgery prevents esophageal adenocarcinoma is a matter of uncertainty. OBJECTIVES: To examine whether antireflux surgery is associated with reduced risk of esophageal adenocarcinoma and whether the risk is different between surgically and medically treated patients. DESIGN, SETTING, AND PARTICIPANTS: In this multinational, population-based retrospective cohort study from Denmark, Finland, Iceland, Norway, and Sweden, patients undergoing surgery were followed up for a median of 12.7 years, and a comparison group of patients receiving medication only were followed up for a median of 4.8 years. All patients with a registered diagnosis of GERD (or an associated disorder), including 48 414 individuals undergoing surgery and 894 492 receiving medication only, were included in the study. The study periods varied in the different countries depending on the year of initiation of registration and the date of data retrieval, from January 1, 1964, to December 21, 2014. EXPOSURES: Antireflux surgery for GERD. MAIN OUTCOMES AND MEASURES: The risk of esophageal adenocarcinoma over time after surgery was compared with that in a corresponding background population using standardized incidence ratios (SIRs) with 95% CIs and with patients with GERD who received medication using multivariable Cox proportional hazards regression, providing hazard ratios (HRs) with 95% CIs adjusted for confounders. RESULTS: In this study of 942 906 patients with GERD, 48 414 underwent antireflux surgery (median [interquartile range] age, 66.0 [58.0-73.0] years; 27 161 male [56.1%]) and 894 492 received medication only (median [interquartile range] age, 71.0 [62.0-78.0] years; 434 035 male [48.6%]). Among patients undergoing surgery, 177 developed esophageal adenocarcinoma. Esophageal adenocarcinoma risk decreased in a time-dependent manner after surgery compared with the background ... Text Iceland PubMed Central (PMC) Gerd ENVELOPE(-45.750,-45.750,-60.666,-60.666) Norway JAMA Oncology 4 11 1576 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Original Investigation |
spellingShingle |
Original Investigation Maret-Ouda, John Wahlin, Karl Artama, Miia Brusselaers, Nele Färkkilä, Martti Lynge, Elsebeth Mattsson, Fredrik Pukkala, Eero Romundstad, Pål Tryggvadóttir, Laufey von Euler-Chelpin, My Lagergren, Jesper Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries |
topic_facet |
Original Investigation |
description |
IMPORTANCE: Gastroesophageal reflux disease (GERD) is associated with a strong and severity-dependent increased risk of esophageal adenocarcinoma. Whether antireflux surgery prevents esophageal adenocarcinoma is a matter of uncertainty. OBJECTIVES: To examine whether antireflux surgery is associated with reduced risk of esophageal adenocarcinoma and whether the risk is different between surgically and medically treated patients. DESIGN, SETTING, AND PARTICIPANTS: In this multinational, population-based retrospective cohort study from Denmark, Finland, Iceland, Norway, and Sweden, patients undergoing surgery were followed up for a median of 12.7 years, and a comparison group of patients receiving medication only were followed up for a median of 4.8 years. All patients with a registered diagnosis of GERD (or an associated disorder), including 48 414 individuals undergoing surgery and 894 492 receiving medication only, were included in the study. The study periods varied in the different countries depending on the year of initiation of registration and the date of data retrieval, from January 1, 1964, to December 21, 2014. EXPOSURES: Antireflux surgery for GERD. MAIN OUTCOMES AND MEASURES: The risk of esophageal adenocarcinoma over time after surgery was compared with that in a corresponding background population using standardized incidence ratios (SIRs) with 95% CIs and with patients with GERD who received medication using multivariable Cox proportional hazards regression, providing hazard ratios (HRs) with 95% CIs adjusted for confounders. RESULTS: In this study of 942 906 patients with GERD, 48 414 underwent antireflux surgery (median [interquartile range] age, 66.0 [58.0-73.0] years; 27 161 male [56.1%]) and 894 492 received medication only (median [interquartile range] age, 71.0 [62.0-78.0] years; 434 035 male [48.6%]). Among patients undergoing surgery, 177 developed esophageal adenocarcinoma. Esophageal adenocarcinoma risk decreased in a time-dependent manner after surgery compared with the background ... |
format |
Text |
author |
Maret-Ouda, John Wahlin, Karl Artama, Miia Brusselaers, Nele Färkkilä, Martti Lynge, Elsebeth Mattsson, Fredrik Pukkala, Eero Romundstad, Pål Tryggvadóttir, Laufey von Euler-Chelpin, My Lagergren, Jesper |
author_facet |
Maret-Ouda, John Wahlin, Karl Artama, Miia Brusselaers, Nele Färkkilä, Martti Lynge, Elsebeth Mattsson, Fredrik Pukkala, Eero Romundstad, Pål Tryggvadóttir, Laufey von Euler-Chelpin, My Lagergren, Jesper |
author_sort |
Maret-Ouda, John |
title |
Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries |
title_short |
Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries |
title_full |
Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries |
title_fullStr |
Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries |
title_full_unstemmed |
Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries |
title_sort |
risk of esophageal adenocarcinoma after antireflux surgery in patients with gastroesophageal reflux disease in the nordic countries |
publisher |
American Medical Association |
publishDate |
2018 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248086/ http://www.ncbi.nlm.nih.gov/pubmed/30422249 https://doi.org/10.1001/jamaoncol.2018.3054 |
long_lat |
ENVELOPE(-45.750,-45.750,-60.666,-60.666) |
geographic |
Gerd Norway |
geographic_facet |
Gerd Norway |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248086/ http://www.ncbi.nlm.nih.gov/pubmed/30422249 http://dx.doi.org/10.1001/jamaoncol.2018.3054 |
op_rights |
Copyright 2018 American Medical Association. All Rights Reserved. |
op_doi |
https://doi.org/10.1001/jamaoncol.2018.3054 |
container_title |
JAMA Oncology |
container_volume |
4 |
container_issue |
11 |
container_start_page |
1576 |
_version_ |
1766042046159650816 |